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The disruption of GDP-fucose 
de novo biosynthesis suggests 
the presence of a novel fucose-
containing glycoconjugate in 
Plasmodium asexual blood stages
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Sabrina Absalon4, Rhoel R. Dinglasan5, John Samuelson2 & Luis Izquierdo1
Glycosylation is an important posttranslational protein modification in all eukaryotes. Besides 
glycosylphosphatidylinositol (GPI) anchors and N-glycosylation, O-fucosylation has been recently 
reported in key sporozoite proteins of the malaria parasite. Previous analyses showed the presence of 
GDP-fucose (GDP-Fuc), the precursor for all fucosylation reactions, in the blood stages of Plasmodium 
falciparum. The GDP-Fuc de novo pathway, which requires the action of GDP-mannose 4,6-dehydratase 
(GMD) and GDP-L-fucose synthase (FS), is conserved in the parasite genome, but the importance of 
fucose metabolism for the parasite is unknown. To functionally characterize the pathway we generated 
a PfGMD mutant and analyzed its phenotype. Although the labelling by the fucose-binding Ulex 
europaeus agglutinin I (UEA-I) was completely abrogated, GDP-Fuc was still detected in the mutant. 
This unexpected result suggests the presence of an alternative mechanism for maintaining GDP-Fuc in 
the parasite. Furthermore, PfGMD null mutant exhibited normal growth and invasion rates, revealing 
that the GDP-Fuc de novo metabolic pathway is not essential for the development in culture of the 
malaria parasite during the asexual blood stages. Nonetheless, the function of this metabolic route 
and the GDP-Fuc pool that is generated during this stage may be important for gametocytogenesis and 
sporogonic development in the mosquito.
Protozoan parasites of the genus Plasmodium are the causative agents of human malaria, the most lethal being 
Plasmodium falciparum. Malaria is a global disease that presents symptoms ranging from fever and headaches to 
seizures, coma and death. Despite all the efforts to control malaria worldwide, 200 million malaria cases that led 
to more than half a million malaria deaths were reported in 20131. Chemotherapy remains the most important 
tool for malaria control, although there are several vaccine candidates currently under evaluation2 and one of 
them has received regulatory approval3.
The life cycle of the parasite is highly complex, including development in two divergent hosts and in different 
tissue compartments. Plasmodium is transmitted to humans by the bite of infected female Anopheles mosquitoes. 
During a blood meal, sporozoites from the mosquito salivary glands are injected to humans and initiate infection 
in the liver. Parasites are then released from the liver into the bloodstream, where they invade red blood cells and 
reproduce asexually. A fraction (1–2%) of the parasites released from infected red blood cells develop into sexual 
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stage gametocytes and are picked up by female Anopheles to initiate the sporogonic life cycle, resulting in the 
generation of sporozoite infection of mosquito salivary glands4.
Cell-surface glycoconjugates are important mediators of host-pathogen interactions for many microbes, 
including protozoan parasites5. Glycosylphosphatidylinositol (GPI) anchors are the major glycosylated mole-
cules on the surface of the Plasmodium parasite6,7. Several GPI-anchored glycoproteins are essential for parasite 
invasion and virulence8 and parasite-derived GPIs, free or associated with protein, induce pro-inflammatory 
responses that contribute to the pathogenesis of malaria9,10. The presence of N-glycosylation of P. falciparum 
proteins has been a controversial issue for years11,12 that was recently solved by the characterization of very short 
N-glycans composed of one or two residues of N-acetylglucosamine (GlcNAc)13,14. However, the extent of pro-
tein N-glycosylation in the blood stages of the parasite seems to be rather low15. Furthermore, the existence of 
O-glycosylation and C-mannosylation in the parasite has been recently reported for the sporozoite stages16.
Sugar nucleotides are activated forms of sugars composed of a monosaccharide and a nucleotide moiety. These 
molecules are formed by either a salvage pathway, involving “activation” of the sugar using a kinase and a pyroph-
osphorylase, or by a de novo pathway, involving the bioconversion of an existing sugar or sugar nucleotide. These 
precursors feed the biosynthesis of glycans by acting as donors for glycosylation reactions17. We recently analysed 
the sugar nucleotide pool in asexuals and found that P. falciparum synthesises five different sugar nucleotides 
including GDP-fucose (GDP-Fuc) or UDP-galactose (UDP-Gal), both of which are not involved in the biosynthe-
sis of the aforementioned GPI-anchors or N-glycans18. Therefore, the presence of these metabolites suggests that 
they may be involved in the biosynthesis of glycans not yet characterised in the parasite19. For example UDP-Gal 
may be required for the synthesis of the α -galactosyl epitopes recently identified in sporozoites20, which seem to 
be absent in the parasite asexual blood stages21. Similarly, GDP-Fuc could be involved in the posttranslational 
modification of thrombospondin type I repeat (TSR) domains present in several key proteins of the malaria 
parasite16,22.
In this work we analysed the functional role of the GDP-Fuc de novo biosynthetic pathway in the blood stages 
of P. falciparum by creating null mutants for GDP-mannose 4,6-dehydratase (GMD) and GDP-L-fucose synthase 
(FS). This metabolic route is not essential for the survival of the parasite in culture. Therefore we analysed the role 
of GDP-Fuc de novo biosynthesis by characterizing the phenotype of the null mutants in vitro.
Materials and Methods
Transfection constructs. To disrupt PfGMD we generated a transfection construct based in the 
pHH1plasmid. pHH1-PfGMD consisted of a ~500 bp sequence, from the start of the gene and with-
out the first 2 nucleotides (AT), cloned into pHH1inv, a plasmid derived from pHH1 that excludes both 
promoter and termination sequences23,24. As a result of a single crossover homologous recombination 
event a disrupted copy of GMD and a copy without the first 2 nucleotides would be generated in parasites 
(Fig. 1A). The PCR product amplified using primers CGCGGTACCGCGAGTTGCTTTAATCTTCG and 
CACCCGCGGCCGCTTATATGATTCTCTATAATTTATTG was cloned into KpnI/NotI restriction sites (under-
lined) of plasmid pHH1inv.
To confirm our results, we also disrupted PfFS using a pCC1-based construct. pCC1-PfFS consisted of two 
fragments of ~1 kb and ~800 bp, respectively, from different regions of the PfFS locus. F1 (nucleotides from 
− 492 to + 526 of the PfFS locus) was amplified using primers ATCCCGCGGGTGTATAATATGTTGGTATAC 
and ATCACTAGTGTTAATGGTAGAGAACAATTTAC and cloned into SacII/SpeI restriction sites (under-
lined) of pCC1 plasmid25. Similarly, F2 (nucleotides 830 to 1584 of PfFS locus) was amplified using primers 
AATCCCATGGACGAATGTATATCTTTTGGG and CTACCTAGGGATCTAATATCTTTATGAGATG and 
cloned into NcoI/AvrII restriction sites (underlined) of the same plasmid. The construct generated would inte-
grate into FS disrupting it by double crossover homologous recombination (Supplementary Figure S1A)25.
Southern blotting. Genomic DNA (gDNA) was isolated by Phenol/Chloroform method from ∼ 600 μ l of 
red blood cells infected with > 5% late trophozoites/schizonts. Two μ g of 3D7- and 3D7Δ GMD-gDNA were 
digested with EcoRI and HindIII in separate reactions and probed with 32P (Perkin Elmer)-labelled PfGMD. 
Similarly, 2 μ g of 3D7-, SRΔ FS- and 3D7Δ FS gDNA were digested with KpnI and HindIII or EcoRI and probed 
with 32P labelled F1 or F2 probes.
Parasite culture and transfection. P. falciparum 3D7 (obtained from MR4-ATCC) parasites were cul-
tured with human B+ erythrocytes (2–4% hematocrit) in RPMI medium (Sigma) supplemented with 10% AB+ 
human serum or 0.5% Albumax II, incubated at 37 °C in an atmosphere of 92% N2, 3% O2 and 5% CO2 using 
standard methods26. Human erythrocytes and serum were purchased from the Banc de Sang i Teixits (Catalonia, 
Spain), after approval from the Comitè Ètic Investigació Clínica Hospital Clínic de Barcelona. Parasite growth was 
monitored by counting the infected erythrocytes in Giemsa-stain blood smears by light microscopy. P. falciparum 
3D7 parasites were transfected as described previously23. Briefly, 150 μ g of each plasmid was used to electroporate 
(310 V, 950 millifarads) 200 μ l of infected red blood cells at > 5% parasitemia, synchronised for ring stage para-
sites. Transfected parasites were selected on 2 nM of WR99210 drug, and resistant parasites appeared in culture 
from 25 to 35 days after drug application. After the appearance of resistant parasites drug cycling with WR99210 
was started. Clonal parasite lines were then derived from WR99210 resistant populations by limiting dilution. To 
calculate growth curves, tightly synchronised parasites were adjusted to 0.5% and measured by FACS. After 48 h 
and 96 h, parasitemia was again determined by FACS using SYTO 11 as previously described27.
Heat-shock experiments. To measure survival to heat-shock28 parasites were sorbitol-synchronised and 
parasitemia adjusted to 1%. Heat shock was performed 22 h after sorbitol treatment by transferring cultures to an 
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incubator at 41.5 °C for 3 h. Control cultures were maintained in a 37 °C incubator all the time. Parasitemia was 
determined by FACS at the next generation when all the schizonts had burst. Resistance to temperature stress 
was calculated by measuring the percentage of growth relative to identical cultures not subjected to heat-shock.
Sugar nucleotide analysis. We synchronised the asexual cultures with sorbitol (or by combining Percoll 
and sorbitol treatments) and performed osmotic lysis of the trophozoite-infected red cells at ~35 h post-invasion 
and 10–12% parasitemia. Briefly, infected and uninfected erythrocyte pellets were resuspended twice in 60 vol-
umes of erythrocyte lysis buffer (10× stock solution: 0.15 M NH4Cl, 0.1 M KHCO3, 0.01 M EDTA) and then incu-
bated on ice for ~10 mins until lysis was completed (31). Pellets, consisting of free parasites and/or erythrocyte 
ghosts, were washed three times with cold phosphate-buffered saline (PBS), lysed in 70% ethanol in the presence 
of 20 pmols of GDP-glucose (GDP-Glc) internal standard, and sugar nucleotides were extracted using Envi-Carb 
(Supelco) columns29,30. Sugar nucleotides were then analysed using liquid chromatography tandem mass spec-
trometry (LC-MS/MS) and multiple-reaction monitoring (MRM) using a TSQ Quantiva Triple Quadrupole Mass 
Spectrometer (Thermo Scientific) or a QTRAP 6500 System (Sciex). A C18 reversed-phase column was used for 
sugar nucleotide separation with a gradient from 0.5% to 4% acetonitrile in 20 mM triethylammonium acetate 
buffer over 20 min at a flow rate of 25 μl/min. Sugar nucleotides were identified by their diagnostic MRM transi-
tions18. The peak areas for each sugar nucleotide, along with their empirically determined molar relative response 
factors and the known amount of internal GDP-Glc, were used to quantify sugar nucleotides. Analyses were 
performed on three different sugar nucleotide extracts30.
Uptake assays using tritiated sugars and GDP-Fuc. 3D7 and PfGMD null mutant parasite cultures 
at 9–12% parasitemia were synchronized to the ring state and then washed and resuspended in RPMI medium 
supplemented with Albumax II. Cells were incubated at 3–4% hematocrit for 16–18 h, until the trophozoite stage. 
Cultures were then treated with saponin to release parasites and washed with glucose-free RPMI supplemented 
with Albumax II and 20 mM fructose. Free parasites were metabolically labeled with 3H-fucose (50 μ Ci/ml) and 
GDP-[3H]Fuc (30 μ Ci/ml) for 2 h, adapting the conditions used in previous works31. The same experiments were 
also repeated with infected RBCs not treated with saponin32. 3H-glucosamine and 3H-L-glucose were used as pos-
itive and negative control, respectively32,33. Triplicates of each condition, and duplicates in the case of GDP-[3H]
Fuc, were included. Labeled parasites were washed three times with PBS at 4 °C and lysed, and the radioactivity 
was measured by liquid scintillation counting.
Fluorescence microscopy. Cultured wild type and mutant P. falciparum lines were washed in PBS and 
fixed in 4% PFA and 0.075% glutaraldehyde in PBS overnight at 4 °C. Fixed cells were washed, permeabilised in 
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Figure 1. PfGMD transfection construct and integration events. (A) Schematic representation of the 
transfection plasmid (pHH1-PfGMD) used to target and disrupt GMD gene in P. falciparum 3D7 parasites 
(3D7) and the expected recombination event (3D7∆ GMD). The small white box in front of F1 fragment 
represents the absence of the first two ‘AT’ nucleotides in the start codon. The black boxes represent upstream 
and downstream DNA sequence flanking the PfGMD gene locus. The position of HindIII (H) and EcoRI 
(E) restriction sites, the position of GMD probe (thick black line) and the predicted length of the restriction 
fragments (thin black lines) are shown. (B) Southern Blot analysis of EcoRI and HindIII digested genomic DNA 
from 3D7 and 3D7Δ GMD parasites. Hybridisation of GMD probe to digested DNA from 3D7Δ GMD revealed 
restriction fragment sizes consistent with the disruption of PfGMD by the single recombination of the plasmid. 
*Matches with the expected size of the episomic plasmid copy. The panel shows a cropped blot and full-length 
blot is shown in Supplementary data (Supplementary Fig. S3).
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0.1% TX-100 in 1xPBS for 5 min at RT, washed again and then blocked in 3% BSA in 1xPBS overnight at 4 °C. 
All washes were performed in 0.5% BSA in 1xPBS by pelleting cells for 2 min at 800 g. Samples were incubated 
in solution 1 h at RT with ∼ 10 μ g/ml Ulex europaeus agglutinin I (UEA-I) and 5 μ g/ml Griffonia simplicifolia 
lectin II (GSL-II) conjugated to either Alexa Fluor488 or 594 (ThermoFisher Scientific). For the sugar inhibition 
experiments, the lectin solution was pre-incubated with 0.2 M methyl-α -fucopyranoside (α MeFuc) for 30 min at 
RT before being added to the cells. Nuclei were stained with 2 μ g/ml DAPI (4,6-diaminido-2-phenylindole) for 
15 min at RT following lectin incubation. Cells were washed in 0.5% BSA in 1xPBS, mounted using Vectashield 
(Vector Labs) and examined by deconvolving fluorescence microscopy using an Olympus IX70 microscope. 
Images were collected at 0.2-μ m optical sections, deconvolved using SoftWoRx (Applied Precision) and further 
processed with Fiji34. Data is presented as a projection of the entire stack.
Results
Generation of PfGMD (3D7ΔGMD) and PfFS (3D7ΔFS) null mutants. To investigate the role of 
GDP-Fuc, we generated null mutants of the enzymes in the de novo biosynthetic pathway for this sugar nucle-
otide. For PfGMD we used a targeting construct (pHH1-PfGMD), which truncated the gene by single homol-
ogous recombination (Fig. 1A)23,24. In addition to the gene disruption, the single recombination event removed 
the first two nucleotides (AT) at the PfGMD start codon. Thus, any translation products generated would be 
expected to yield aberrant or non-functional proteins. Southern blot analysis of restriction enzyme-digested 
DNA using a PfGMD probe showed that the gene was mutated as intended (Fig. 1B). The isolation of 3D7Δ 
GMD mutants indicated that the gene was not essential. To confirm our results, we also disrupted the PfFS 
locus using a double-crossover recombination approach based on a pCC1-targeting construct (pCC1-PfFS) 
(Supplementary Fig. S1A)25. The disruption of both genes in the GDP-Fuc de novo pathway allow us to conclude 
that this metabolic route is not required for the survival of the blood stages of the parasite in culture.
PfGMD null mutants did not exhibit a growth phenotype in vitro. 3D7Δ GMD null mutant par-
asites showed growth rates similar to the 3D7 wild type strain (Fig. 2A), indicating that the GDP-Fuc de novo 
biosynthetic pathway is not necessary during in vitro blood stage development. In line with the above, we did not 
observe patent changes in cell size and morphology at the trophozoite stage between wild type and the mutant 
cell line (Fig. 2B).
Given that we did not observe a reduced growth phenotype for 3D7Δ GMD null mutants under in vitro con-
ditions, we hypothesized that parasite survival may be impacted under stressful conditions. Glycosyltransferase 
Figure 2. P. falciparum 3D7ΔGMD grow at comparable rates to 3D7 control cell lines. (A) Synchronous 
ring-stage 3D7Δ GMD and 3D7 growth was monitored over two complete life cycles (96h) by flow cytometry. 
(B) Intraerythrocytic development (x1000 magnification) of wild-type (3D7) and PfGMD (Δ GMD) 
null mutants of P. falciparum 3D7 strain. Time indicates hours post-invasion of tightly (5 hours window) 
synchronised in vitro cultures by means of a combination of Percoll and sorbitol treatments. (C) Inhibition 
of 3D7 (dark grey bar) and 3D7Δ GMD (light grey bar) growth by a 3-h heat-shock at 41.5 °C. Values are the 
average of three independent replicas, with standard deviation, and represent percentage of growth relative 
to identical cultures not subjected to heat-shock. Heat-shock was performed when parasites were at the 
trophozoite stage and parasitemia was measured by FACS at the next generation. Statistical analysis, performed 
by applying one-way analysis of variance Tukey’s post-test, showed no significant differences.
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activity and sugar nucleotides donors have long been linked to protein folding and thermotolerance in many 
organisms, including different parasites35–37. It has been suggested that Protein O-fucosyltransferase 2 (PoFUT2), 
of which a homolog is conserved and expressed in the P. falciparum genome18, may be involved in a novel quality 
control mechanism for the proper folding of TSR-domain containing proteins in the endoplasmic reticulum 
(ER)37,38. Proteins with TSR-domains have been shown to be expressed in asexual stages and to be involved in 
host-cell invasion39,40. To assess if abrogation of the GDP-Fuc de novo pathway could alter PoFUT2 function in the 
parasite, we studied the ability of 3D7Δ GMD mutant to cope with conditions likely to lead to the accumulation 
of misfolded TSR-containing proteins in the ER by measuring parasite growth after a 3 h heat shock at 41.5 °C. 
We did not observe any significant difference in resistance to heat shock in the mutant cell line compared to wild 
type, as judged by growth rate after temperature stress (Fig. 2C). Similar results were also observed for 3D7Δ FS 
cell line (Supplementary Fig. S1C).
GDP-Fuc is still detected in the parasite after disruption of the GDP-Fuc de novo pathway. To 
analyse the effect of PfGMD mutagenesis on parasite GDP-Fuc levels, sugar nucleotides from trophozoites were 
extracted, separated by reverse phase HPLC and quantified by multiple reaction monitoring tandem mass spec-
trometry using an internal standard (GDP-Glc) not present in P. falciparum blood stages30. We performed several 
biological replicates of the analyses, anticipating certain variability of the dynamic pools of sugar nucleotides. 
Nevertheless, the presence of GDP-Fuc in the mutant cell line was observed in all the experiments (Fig. 3A and 
Supplementary Table SI). Furthermore, the ratios between GDP-Fuc and other sugar nucleotides were similar 
throughout the different analyses, suggesting that there was not a specific reduction of the GDP-Fuc levels.
The detection of GDP-Fuc in the mutants strongly suggests the presence of an alternative pathway in the par-
asite for the generation of this sugar nucleotide. In order to identify an alternative mechanism of fucose transport 
and activation in PfGMD null mutants, we used tritiated sugar to perform uptake assays in infected RBCs or 
saponin-released parasites. However, no specific incorporation was observed in the PfGMD mutant cell line using 
either free fucose or GDP-Fuc (Fig. 3B).
Fucose-binding lectin Ulex europaeus agglutinin 1 (UEA-I) labelling is abrogated in parasites 
with a disrupted GDP-Fuc de novo pathway. UEA-I, which has affinity for α -linked-fucose, binds to 
red blood cells (RBCs) membranes and also to wild type parasite surfaces (Fig. 4A). The UEA-I binding is absent 
in PfGMD null mutant parasites, suggesting that the mutation affects lectin binding to the surface of the parasite. 
On the contrary Griffonia simplicifolia lectin II (GSL-II) labelling, a GlcNAc-specific lectin which binds to P. 
falciparum N-glycans on the surface of the parasite and co-localises with UEA-I in wild type cells, is not affected 
in mutants (Fig. 4B)13. Therefore, GSL-II and UEA-I bind likely to different glycosylated structures on the plasma 
membrane of the parasite, but only UEA-I labelling is affected in mutants. UEA-I labelling specificity was con-
firmed by binding inhibition after lectin preincubation with α MeFuc (Supplementary Fig. S2).
Discussion
Glycoconjugate biosynthesis requires the activation of monosaccharides to nucleotide sugars. These precur-
sors are used by different glycosyltransferases for diverse glycosylation reactions41. Only five sugar nucleotides 
Figure 3. A pool of GDP-Fuc is detected in 3D7ΔGMD mutants. (A) The levels of GDP-Fuc and other 
sugar nucleotides are quantified in wild type (3D7; white bars) and 3D7Δ GMD mutants (grey bars). Values are 
shown as relative amounts to wild type sugar nucleotide levels and indicate the average variation ± S.D. of five 
different analyses. Analyses of every single experiment were always performed in triplicate. (B) Picomols of free 
3H-fucose (light grey bars) and GDP-[3H]Fuc (dark grey bars) incorporated by wild type (3D7) and 3D7Δ GMD 
mutant parasites in culture (top) or after saponin treatment to release parasites (bottom). 3H-L-glucose (white 
bars) is included for comparison purposes, as it is incorporated through equilibrative (not active) transport 
mechanisms45. A control of 3H-glucosamine, incorporated by parasites15,32, was also used in every experiment 
(not shown).
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have been identified in the blood stages of P. falciparum: UDP-N-acetylglucosamine (UDP-GlcNAc), UDP-Gal, 
UDP-glucose (UDP-Glc), GDP-mannose (GDP-Man) and GDP-Fuc18. P. falciparum genome encodes and 
expresses homologues of GMD and FS, the enzymes responsible for the de novo biosynthesis of GDP-Fuc from 
GDP-Man42. Tritiated fucose is not taken-up significantly from the media by the parasite during the intraerythro-
cytic life cycle, which is consistent with the apparent absence of genes encoding for the GDP-Fuc salvage pathway 
in the parasite genome18,43,44. Altogether, this suggested that most, if not all, of the GDP-Fuc present is formed 
by the bioconversion of GDP-Man18. Surprisingly, the detection of GDP-Fuc in PfGMD mutants (Fig. 3A and 
Supplementary Table SI) implies that a substantial alternative source of GDP-Fuc is still present and active in 
the parasite. Our analyses with null mutant cell lines did not reveal the existence of an evident route for the 
incorporation of free fucose or GDP-Fuc (Fig. 3B). Nevertheless, it has to be considered that human erythrocytes 
contain significant levels of fucosylated proteins and their putative degradation may release monosaccharides that 
might be activated by the parasite. Furthermore, red blood cells also have a significant pool of GDP-Fuc (data not 
shown) which might be scavenged by the parasite during the intraerythrocytic life cycle. In this sense, previous 
studies had suggested that P. falciparum may obtain some sugars and/or other metabolites through passive mech-
anisms during the intraerythrocytic life cycle45,46.
A considerable variability in sugar nucleotide levels between different biological replicates was observed, 
independently of the synchronization method used (Fig. 3A). This disparity is possibly derived from inter-assay 
variability, differences on the sources of RBCs for in vitro culture or even fluctuations of the dynamic pools of 
sugar nucleotides in parasites. Nevertheless, GDP-Fuc was always detected and there was not a specific reduction 
of this sugar nucleotide in comparison to the rest of the pools, suggesting that the GDP-Fuc de novo pathway may 
not represent a significant contribution to the levels of GDP-Fuc in the blood stages of the parasite. Furthermore, 
mutant cell lines did not present alterations in their growth in vitro (Fig. 2A and Supplementary Fig. S1B). This 
also seems to be the case in P. berghei Δ GMD and Δ FS mutants47. Further studies may help to completely dissect 
the impact of the disruption of the GDP-Fuc de novo route in other stages of the parasite life cycle.
Nevertheless, fluorescence microscopy assays using AlexaFluor488-labelled UEA-I and performed on 
detergent-permeabilised and parasitised erythrocytes showed a striking reduction in lectin binding to the para-
site membrane in PfGMD null mutant (Fig. 4B). Despite the presence of GDP-Fuc in the mutant, this reduction 
in UEA-I binding to a fucose glycotope might somehow be related to the disruption of a source of GDP-Fuc, 
namely the de novo pathway. If this metabolic route contributes even in part to the metabolite pool, mutants could 
be reacting to a marginal decrease of GDP-Fuc by shutting down the biosynthesis of fucose-containing glycans 
dispensable for in vitro growth (Fig. 4B). Examples of glycan biosynthesis cessation as adaptation to a lower avail-
ability of precursors have been reported recently48.
The decrease of UEA-I binding strongly suggests the presence of a fucose-containing glycan on the surface 
of P. falciparum blood stages. Despite several attempts, we were not successful in reproducing the observed 
differences by Western blot (not shown) perhaps indicating that UEA-I binds to a glycolipid in the parasites. 
UEA-I is best known for its ability to agglutinate human erythrocytes by binding to the α -1,2-fucose-contaning 
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Figure 4. UEA-I labelling is abrogated in 3D7ΔGMD mutants. (A) Deconvolving micrographs of P. 
falciparum infected RBCs show a specific UEA-I labelling (green) on the surface of wild type parasites and host 
RBCs. GSL-II also binds to the surface of parasites13 (B) UEA-I labelling disappears in 3D7Δ GMD mutant 
surface (bottom panels) whereas GSL-II binding is not altered.
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H-antigen49. Only erythrocytes of the rare Bombay phenotype, which are completely devoid of such epitopes due 
to an inactivated mutation in the α -1,2-fucosyltransferase gene (FUT1), are not agglutinated50,51. The reduction 
in UEA-I binding in mutant parasites indicates that a fucosyl transferase may be involved in the synthesis of a 
UEA-I-glycotope on the surface of the parasite.
No putative α -1,2-fucosyltransferase can be identified in the P. falciparum genome by bioinformatic searches, 
however a homolog of PoFUT2 (PF3D7_0909200) is present. PoFUT2 is involved in the O-fucosylation of 
TSR-domains in other organisms38. Peptides belonging to this putative PfPoFUT2 have been detected in the 
sporozoite stages of the parasite52, when large amounts of TSR-containing proteins such as the circumsporo-
zoite protein (CSP) and thrombospondin-related adhesive protein (TRAP) are expressed and posttranslationally 
modified16. Hence, there is the possibility that the de novo GDP-Fuc disruption results in a more striking phe-
notype during sporozoite development in the mosquito, potentially affecting both salivary gland and hepatocyte 
invasion. P. falciparum PoFUT2 gene is also upregulated during the schizont stages of the intraerythrocytic life 
cycle18 and therefore it may be involved in the fucosylation of other TSR-domain containing proteins required 
for host-cell invasion in these stages16,39,40,53. Although PfPoFUT2 might be the fucosyltransferase involved in the 
biosynthesis of the UEA-I glycotope, there is also the possibility that other GDP-Fuc-dependent transferases are 
present and active throughout the blood stages of P. falciparum. Further work is being carried out at present to 
characterise this glycan modification and the glycosyl transferase/s involved in its biosynthesis.
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